Asepha

Asepha

AI clinical tools to enable automation and personalization in pharmacies.

HQ location
Toronto, Canada
Website
Launch date
Employees
Enterprise value
$16—24m
  • Edit
Notes (0)
More about Asepha
Made with AI
Edit

Asepha is a health technology company targeting the operational inefficiencies within the pharmacy sector. Founded in 2023 by Dr. Eunice Wu, a pharmacist, and Can Uncu, an AI engineer, the Toronto-based startup aims to automate the manual, administrative tasks that consume a significant portion of a pharmacist's time. Dr. Wu's firsthand experience with the frustrations of administrative overload in various hospital and retail pharmacies across Canada inspired the company's creation. She observed that up to 90% of a pharmacist's workday is spent on manual work, which detracts from patient care. Uncu brings technical expertise from his time at AMD, where he worked on the MI300X chip, an integral component now used by major tech companies.

The company develops artificial intelligence agents to streamline and automate core pharmacy workflows. Asepha's product suite is a modular platform designed to integrate with existing pharmacy systems without requiring new interfaces. One of its key features is an Optical Character Recognition (OCR) agent capable of processing complex, handwritten prescriptions with 96% accuracy, thereby reducing manual data entry. Another offering is an AI-powered call agent that can automate up to 70% of inbound phone triage, addressing common inquiries and freeing up staff. The platform also includes a browser navigation agent to handle repetitive, web-based administrative tasks. The business serves enterprise clients, including Fortune 50 companies, and is operational in the U.S., Canada, and Australia.

Asepha's business model centers on providing these AI-driven automation tools to pharmacies, enabling them to reduce administrative burdens, increase the volume of clinical services, and capture revenue from billable services that were previously trapped in manual processes. The company has secured $4 million in a seed funding round led by Glasswing Ventures and Core Innovation Capital, with participation from several other venture firms. This capital is intended to scale its engineering and go-to-market teams, expand its U.S. operations with a new office in New York City, and deepen its global partnerships.

Keywords: pharmacy automation, AI in healthcare, healthtech, pharmacy workflow, prescription data entry, OCR for prescriptions, AI call agent, medication management, clinical task automation, pharmacy operations, Eunice Wu, Can Uncu, pharmacy AI, digital health, administrative task automation, healthcare AI, pharmacy software, medication reconciliation, prescription intake, drug therapy problems, agentic AI

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads